CTOR

Citius Oncology
CTOR

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $43.8M invested in Citius Oncology in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.76M
2
+$1.28M
3
+$141K
4
QL
Quarry LP
New York
+$2.27K
5
WRBC
W.R. Berkley Corp
Connecticut
+$2.27K

Top Sellers

1
-$4.13M
2
-$2.21M
3
-$1.83M
4
WAM
Wolverine Asset Management
Illinois
-$59.2K
5
GCL
Glazer Capital LLC
New York
-$51.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.12M
2
$6.02M
3
$4.62M
4
$3.98M
5
$3.86M
6
$3.48M
7
$3.4M
8
$3.39M
9
$2.76M
10
$2.56M
11
$2.27M
12
$319K
13
$466
14
–
15
–
16
–